Circle of Care supports the cystic fibrosis community by funding innovative, patient-centered programs that help people living with the disease lead fuller, more engaged lifestyles.
Funder: Vertex Pharmaceuticals
Due Dates: 2026 cycle (applications accepted)
Funding Amounts: Vertex generally limits annual support to 30% of an organization’s annual operating budget
Summary: Supports innovative, patient-centric programs that help people with cystic fibrosis live fuller, more engaged lifestyles.
Key Information: Global opportunity supporting programs in countries where Vertex operates.
Circle of Care is a global competitive grant program from Vertex Pharmaceuticals supporting the cystic fibrosis (CF) community. It funds innovative, patient-centric programs that help people with CF live fuller, more engaged lifestyles. Recipients in each grant cycle are selected by an independent steering committee whose members are part of the CF community.
The program sits within Vertex’s broader support for initiatives that advance knowledge and care for people living with CF and other serious diseases in its research focus areas. That support seeks to encourage innovation, strengthen scientific research, educate health care professionals, and address unmet community needs. Circle of Care provides a dedicated opportunity for programs centered on people with CF.